Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Needle-free Precision Delivery Systems
PharmaJet, a company engineering precision delivery systems that may overcome the challenges of nucleic acid […]
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO
Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]
José Baselga Research Fund Announces First-Ever Grant to Advance Prion Disease Research
The José Baselga Research Fund (JBRF), supported by Alexion, AstraZeneca Rare Disease, today announced the […]
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China
TaiGen Biotechnology Company announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical […]
Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease
Roche announced today that it has entered into a collaboration with Eli Lilly and Company […]
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that […]
Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS)
Coya Therapeutics, a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg function, […]
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey
BeiGene, a global biotechnology company, announced today that the last piece of structural steel will […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more